These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 23025847

  • 21. Ovine colostrum nanopeptide affects amyloid beta aggregation.
    Janusz M, Woszczyna M, Lisowski M, Kubis A, Macała J, Gotszalk T, Lisowski J.
    FEBS Lett; 2009 Jan 05; 583(1):190-6. PubMed ID: 19084010
    [Abstract] [Full Text] [Related]

  • 22. Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease.
    O'Hare E, Scopes DI, Kim EM, Palmer P, Spanswick D, McMahon B, Amijee H, Nerou E, Treherne JM, Jeggo R.
    Int J Neuropsychopharmacol; 2014 Jan 05; 17(1):117-26. PubMed ID: 24103729
    [Abstract] [Full Text] [Related]

  • 23. Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death.
    Kang IJ, Jeon YE, Yin XF, Nam JS, You SG, Hong MS, Jang BG, Kim MJ.
    Food Chem Toxicol; 2011 Sep 05; 49(9):2252-9. PubMed ID: 21693162
    [Abstract] [Full Text] [Related]

  • 24. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y, Wang XP, Yang SG, Wang YJ, Zhang X, Du XT, Sun XX, Zhao M, Huang L, Liu RT.
    Neurotoxicology; 2009 Nov 05; 30(6):986-95. PubMed ID: 19744518
    [Abstract] [Full Text] [Related]

  • 25. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
    Wu WH, Liu Q, Sun X, Yu JS, Zhao DS, Yu YP, Luo JJ, Hu J, Yu ZW, Zhao YF, Li YM.
    Biochem Biophys Res Commun; 2013 Sep 27; 439(3):321-6. PubMed ID: 24012671
    [Abstract] [Full Text] [Related]

  • 26. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
    Veloso AJ, Kerman K.
    Bioelectrochemistry; 2012 Apr 27; 84():49-52. PubMed ID: 21967982
    [Abstract] [Full Text] [Related]

  • 27. Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.
    Yang SG, Zhang X, Sun XS, Ling TJ, Feng Y, Du XY, Zhao M, Yang Y, Xue D, Wang L, Liu RT.
    J Alzheimers Dis; 2010 Apr 27; 22(1):107-17. PubMed ID: 20847437
    [Abstract] [Full Text] [Related]

  • 28. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
    Kimura M, Akasofu S, Ogura H, Sawada K.
    Brain Res; 2005 Jun 14; 1047(1):72-84. PubMed ID: 15893738
    [Abstract] [Full Text] [Related]

  • 29. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
    Okada T, Wakabayashi M, Ikeda K, Matsuzaki K.
    J Mol Biol; 2007 Aug 10; 371(2):481-9. PubMed ID: 17582434
    [Abstract] [Full Text] [Related]

  • 30. Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster.
    Pratim Bose P, Chatterjee U, Nerelius C, Govender T, Norström T, Gogoll A, Sandegren A, Göthelid E, Johansson J, Arvidsson PI.
    J Med Chem; 2009 Dec 24; 52(24):8002-9. PubMed ID: 19908889
    [Abstract] [Full Text] [Related]

  • 31. Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity.
    Andreetto E, Yan LM, Caporale A, Kapurniotu A.
    Chembiochem; 2011 Jun 14; 12(9):1313-22. PubMed ID: 21630409
    [Abstract] [Full Text] [Related]

  • 32. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O.
    J Neurochem; 2008 Dec 14; 107(6):1634-46. PubMed ID: 19014387
    [Abstract] [Full Text] [Related]

  • 33. Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats.
    Orbán G, Völgyi K, Juhász G, Penke B, Kékesi KA, Kardos J, Czurkó A.
    Brain Res; 2010 Oct 01; 1354():227-35. PubMed ID: 20659435
    [Abstract] [Full Text] [Related]

  • 34. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E.
    J Neurosci Res; 2007 Feb 15; 85(3):623-33. PubMed ID: 17131391
    [Abstract] [Full Text] [Related]

  • 35. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T, Suzuki K, Hoshino T, Mizushima T.
    J Neurochem; 2015 Aug 15; 134(4):611-7. PubMed ID: 25963375
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
    Catto M, Berezin AA, Lo Re D, Loizou G, Demetriades M, De Stradis A, Campagna F, Koutentis PA, Carotti A.
    Eur J Med Chem; 2012 Dec 15; 58():84-97. PubMed ID: 23108363
    [Abstract] [Full Text] [Related]

  • 37. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
    Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, de Waal RM, Verbeek MM.
    Brain Res; 2006 May 17; 1089(1):67-78. PubMed ID: 16635482
    [Abstract] [Full Text] [Related]

  • 38. Ion mobility spectrometry reveals the mechanism of amyloid formation of Aβ(25-35) and its modulation by inhibitors at the molecular level: epigallocatechin gallate and scyllo-inositol.
    Bleiholder C, Do TD, Wu C, Economou NJ, Bernstein SS, Buratto SK, Shea JE, Bowers MT.
    J Am Chem Soc; 2013 Nov 13; 135(45):16926-37. PubMed ID: 24131107
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and biophysical evaluation of arylhydrazono-1H-2-indolinones as β-amyloid aggregation inhibitors.
    Campagna F, Catto M, Purgatorio R, Altomare CD, Carotti A, De Stradis A, Palazzo G.
    Eur J Med Chem; 2011 Jan 13; 46(1):275-84. PubMed ID: 21144622
    [Abstract] [Full Text] [Related]

  • 40. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
    Cui L, Zhang Y, Cao H, Wang Y, Teng T, Ma G, Li Y, Li K, Zhang Y.
    J Alzheimers Dis; 2013 Jan 13; 37(1):19-28. PubMed ID: 23727899
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.